Table 1 Overview of meta-analysis dataset clinical characteristics (n = 86).
From: Analysis of bronchoalveolar lavage fluid metatranscriptomes among patients with COVID-19 disease
Variable | Uninfected | Community acquired pneumonia | COVID-19 |
|---|---|---|---|
Cohort | 29 (33.72%) | 25 (29.07%) | 32(37.21%) |
Outcome (COVID-19 only) | |||
Deceased | – | – | 10 (31.25%) |
Survived | – | – | 15 (46.87%) |
Unspecified | – | – | 7 (21.88%) |
Sex | |||
Female (n = 22) | 4 (18.18%) | 8 (36.36%) | 10 (45.45%) |
Male (n = 38) | 5 (13.15%) | 11 (28.94%) | 22 (57.89%) |
Unspecified (n = 26) | 20 (76.92%) | 6(23.07%) | 0 (0%) |
Reads | |||
Paired | 29 (37.18%) | 25 (32.05%) | 24 (30.77%) |
Single | 0 (0%) | 0 (0%) | 8 (100%) |
Publication | |||
Chen | 0 (0%) | 0 (0%) | 2 (100%) |
Ren | 9 (100%) | 0 (0%) | 0 (0%) |
Shen | 20 (32.79%) | 25 (40.98%) | 16 (40.98%) |
Wu | 0 (0%) | 0 (0%) | 1 (100%) |
Xiong | 0 (0%) | 0 (0%) | 4 (100%) |
Zhou | 0 (0%) | 0 (0%) | 9 (100%) |
Numeric variables (mean ± SD) | |||
Age | 53.2 ± 13.3 (n = 9) | 51.2 ± 19.8 (n = 17) | 47.3 ± 11.5 (n = 32) |
Temp. °C | – | 38.4 ± 0.91 (n = 15) | 38.4 ± 0.715 (n = 8) |
Days after onset | – | 9.07 ± 3.17 (n = 14) | 12.05 ± 6.5 (n = 41) |
